Facebook Facebook Share

Target Ovarian Cancer is monitoring closely the developments relating to the COVID-19 pandemic and the guidance from government bodies. We are committed to minimising the impact on our research programme during this period of uncertainty. We want to enable the researchers that we fund to be safe and support their families, and for clinicians to support the NHS where required.

We have taken the decision to postpone the 2020 grant round for translational research awards until later this year. We will be reviewing the situation in June 2020, when we will provide further information about the timetable for the next round.

Our translational research award is for an innovative research project which will benefit the largest proportion of women with ovarian cancer in the shortest timeframe. This project will receive up to £200,000 of funding.

What we’re looking for

Projects that will optimise and develop more effective and less toxic treatments for ovarian cancer, with a special focus on treatments that will improve overall survival. These awards are not designed for basic or early discovery studies.

Many important challenges need to be overcome to improve treatments for patients. Some examples are provided below, however Target Ovarian Cancer will consider support for any research of relevance to optimising or developing new treatments.

  • Identify new drug targets within subtypes of ovarian cancer and develop new targeted treatments
  • Understand why tumours develop resistance to therapies, developing strategies to prevent and overcome resistance
  • Develop new immunologic approaches to treating ovarian cancer
  • Understand the effectiveness of existing drugs against different tumour subtypes
  • Understand the effectiveness of specific drug combinations in subtypes
  • Research to predict which patients will benefit from chemotherapy
  • Develop appropriate treatments for older patients
  • Identify prognostic markers that indicate response to treatment
  • Develop robust surgical trials to validate new technologies and optimise treatments

All research project proposals are reviewed by our Scientific Advisory Board members and lay Research Advocates.

For further information about our priorities, read a summary of our Research Strategy.


Before you fill in the project proposal form, please complete our application checklist:

Further information

Target Ovarian Cancer does not receive any government funding. This research is only made possible through donations and legacies. If you would like to contribute to these research projects and improve the lives of women with ovarian cancer, please support us.